Evidence map›Paper›PMID 40538114›Full record

ReviewEar, nose, & throat journal2025

Cytokine Sampling in the Nasal Cavity and Paranasal Sinuses.

Yasine Mirmozaffari, Michael Ly, Ezer H Benaim, Luke O Barron, Meghan E Rebuli

Abstract readReview
In one paragraph

Review in Ear, nose, & throat journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yasine MirmozaffariSchool of Medicine, University of North Carolina at Chapel Hill, NC, USA.ORCID 0009-0002-2529-2161
Michael LySchool of Medicine, University of North Carolina at Chapel Hill, NC, USA.
Ezer H BenaimDepartment of Otolaryngology - Head and Neck Surgery, University of North Carolina at Chapel Hill, NC, USA.ORCID 0000-0001-8190-0091
Luke O BarronHealth Sciences Library, University of North Carolina at Chapel Hill, NC, USA.
Meghan E RebuliCenter for Environmental Medicine, Asthma and Lung Biology, School of Medicine, University of North Carolina at Chapel Hill, NC, USA.ORCID 0000-0003-1918-2257

Funding

Research Training in OtolaryngologyT32DC005360 · NIDCD · UNIV OF NORTH CAROLINA CHAPEL HILL · PI MANIS, PAUL B · 2003 to 2023
$2.8M
Impact of sex on respiratory response to wood smoke exposureK01ES032837 · NIEHS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI REBULI, MEGHAN ELIZABETH · 2022 to 2024
$457k
NIDCD NIH HHS T32 DC005360NIEHS NIH HHS K01 ES032837
6 · The paper itself

Abstract

backgroundCytokines are crucial mediators in cell-to-cell communication, immune regulation, and the pathophysiology of rhinologic diseases. Distinguishing cytokine profiles can elucidate inflammation types [eg, T-helper type 1 (Th1), Th2, and Th17] and guide therapeutic options. Various methods for cytokine sampling in the sinonasal cavity exist. This review aimed to provide an in-depth review of these methods, including their advantages, limitations, and analytical techniques.

methodsA narrative literature review was conducted using Medical Subject Headings (MeSH) keywords in PubMed and Google Scholar. Key MeSH terms include "cytokines," "mucus," "interleukins," "biomarkers," "sinonasal disease," "chemokines," "paranasal sinuses," and "sampling."

resultsThere are many different methods of cytokine sampling in the sinonasal cavity. Common methods include nasal lavage, forced exhalation, collection of nasal epithelial lining fluid, nasopharyngeal swab, cytobrush, sponge, suction, and tissue biopsy. Each method used has advantages and limitations, such as type of sample collected, location specificity, invasiveness, sample dilution and volume variability, and utility for downstream analytical assays.

conclusionsAdvancements in cytokine sampling and pharmacological targeting in sinonasal disease are instrumental for the diagnosis and management of patients with sinonasal disease. Understanding these methods' strengths and weaknesses can improve patient care and guide treatment development.

Indexed as

biomarkerschemokinesinterleukinsnasal cavitysinus

Identifiers

PMID40538114
PMCPMC12777681

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.